Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Charles River Laboratories International, Inc. and Ziphius Vaccines, a biopharmaceutical company developing self-amplifying RNA (saRNA) based medicinal products for vaccine and therapeutic applications, announced an agreement to manufacture starting ...
read more
mdgroup, the global digital and patient servicing company pioneering a patient-first approach to clinical research, is proud to sponsor brain cancer research and patient support group, Gladiator Project, with its upcoming Spring Classic golf ...
read more
BioAgilytix Labs, LLC (“BioAgilytix”), a leading global contract research organization focused on supporting pharmaceutical and biotech partners in all phases of drug development, announces the appointment, effective immediately, of Euan Menzies as ...
read more
To mark its 10th anniversary, NuChem Sciences, Canada's largest contract research organization (CRO) in drug discovery chemistry, recently inaugurated its new laboratories located on Dobrin Street in Montreal.
read more
Piramal Pharma Limited's Pharma Solutions announced the appointment of Herve Berdou as Chief Operating Officer, Piramal Pharma Solutions (PPS).
read more
Avania, a full-service global MedTech contract research organization (“CRO”), announced that Astorg has acquired a majority stake in the company.
read more
Humanigen, Inc. announced it entered into an agreement with PCI Pharma Services (PCI), a integrated global contract development manufacturing organization (CDMO), to provide importation, release and commercialization services in the United Kingdom (...
read more
Scorpion Biological Services (Scorpion), a biopharmaceutical contract development and manufacturing organization (CDMO) and contract research organization (CRO), today announced the appointment of Stephan Kutzer, Ph.D. as its Interim Chief Executive ...
read more
ValGenesis, Inc. has acquired Portugal-based 4Tune Engineering (4TE), a provider of manufacturing sciences and technologies (MS&T) that enable the world's most successful life sciences companies to model their risk management programs and improve ...
read more
Lumanity announced the acquisition of Endpoint Outcomes, a company specializing in harnessing the voice of patients to document the impact of treatments on health-related quality of life.
read more
Piramal Pharma Limited’s Pharma Solutions business announced that the company’s site in Digwal in the state of Telangana, India, has implemented various tools to unlock Active Pharmaceutical Ingredient (API) manufacturing capacity and support client ...
read more
EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced the appointment of Colin McCracken as Chief Executive Officer with immediate effect.
read more
Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) today provided an update on progress at Rentschler ATMP Ltd., the Company’s dedicated cell and gene therapy facility located in Stevenage, UK, including...
read more
Avid Bioservices, Inc. announced that the company is further expanding its process development capacity for its mammalian cell business. As part of these efforts, Avid is expanding its state-of-the-art laboratories which could support an additional $...
read more
Charles River Laboratories International, Inc. and ASC Therapeutics announced they have agreed to manufacture ASC618, a second-generation gene therapy for hemophilia A.
read more